Cardiff Oncology, Inc. Income Statement

Income Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.27M0.26M0.45M0.26M0.28M0.31M0.38M0.51M0.38M0.24M0.37M0.36M0.39M0.49M0.68M
Gross Profit -0.06M-1.27M-2.45M-6.13M-11.14M-1.31M-0.22M
Operating items
Amortization - Deferred Charges 0.22M2.35M
Research & Development 1.02M0.91M1.92M3.95M6.66M10.59M15.01M7.88M8.16M11.16M11.23M17.38M27.11M32.86M36.85M
Selling, General & Administrative 1.95M2.32M2.87M5.47M5.81M7.92M11.48M14.23M8.01M5.76M8.22M11.84M13.18M13.04M12.48M
Restructuring Costs 0.79M2.17M0.66M
Other Operating Expenses 2.67M0.51M-0.02M0.02M-0.00M-0.14M-0.17M-0.24M0.00M-0.03M
Operating Expenses 5.64M3.23M5.30M10.95M15.23M25.59M40.53M26.10M17.43M16.92M19.45M29.21M40.29M45.90M49.33M
Operating Income -5.38M-2.98M-4.85M-10.69M-14.95M-25.27M-40.15M-25.60M-17.05M-16.68M-19.09M-28.86M-39.90M-45.41M-48.65M
EBIT -5.38M-2.98M-4.85M-10.69M-14.95M-25.27M-40.15M-25.60M-17.05M-16.68M-19.09M-28.86M-39.90M-45.41M-48.65M
Non-operating items
Interest & Investment Income 182.00171.000.00M0.01M0.06M0.30M0.15M0.22M0.23M0.09M0.26M1.58M4.07M3.26M
Other Non Operating Income 0.27M0.62M-6.72M-1.08M1.43M-0.73M2.46M3.40M0.62M0.03M-0.28M0.28M-0.38M-0.10M-0.04M
Non Operating Income -0.22M0.56M1.20M3.97M3.22M
Net income details
EBT -5.26M-3.03M-4.85M-10.70M-15.78M-26.74M-41.52M-26.48M-16.86M-16.44M-19.00M-28.59M-38.32M-41.34M-45.39M
Profit After Tax 5.45M-42.04M-11.57M-11.81M-14.33M-27.47M-39.20M-24.91M-16.46M-16.41M-19.31M-28.29M-38.70M-41.44M-45.43M
Income from Continuing Operations -5.26M-3.03M-4.85M-10.70M-15.78M-26.74M-41.52M-26.48M-16.86M-16.44M-19.00M-28.59M-38.32M-41.34M-45.39M
Consolidated Net Income -5.26M-3.03M-4.85M-10.70M-15.78M-26.74M-41.52M-26.48M-16.86M-16.44M-19.00M-28.59M-38.32M-41.34M-45.39M
Income towards Parent Company -5.26M-3.03M-4.85M-10.70M-15.78M-26.74M-41.52M-26.48M-16.86M-16.44M-19.00M-28.59M-38.32M-41.34M-45.39M
Preferred Dividend Payments 0.04M0.04M0.04M0.03M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M
Net Income towards Common Stockholders -5.49M-2.28M-11.60M-11.84M-14.35M-27.50M-39.23M-24.93M-19.25M-16.71M-22.60M-28.32M-38.73M-41.47M-45.45M
Additional items
EPS (Basic) -35.30-0.23-0.89-0.70-0.76-1.05-1.30-51.76-8.26-2.80-1.08-0.73-0.89-0.93-0.95
EPS (Weighted Average and Diluted) -0.13-0.04-0.89-0.70-0.88-1.21-1.37-51.76-8.26-1.08-0.73-0.89-0.93-0.95
Shares Outstanding (Weighted Average) 0.16M0.16M0.20M0.26M0.26M0.41M0.43M0.53M3.83M7.74M35.32M39.55M44.68M44.68M51.13M
Shares Outstanding (Diluted Average) 42.95M58.27M16.98M19.07M30.16M30.71M0.48M2.33M20.88M39.03M43.60M44.68M47.65M
EBITDA -5.38M-2.98M-4.85M-10.69M-14.95M-25.27M-40.15M-25.60M-17.05M-16.68M-19.09M-28.86M-39.90M-45.41M-48.65M
Interest Expenses -0.12M0.06M0.02M0.84M1.53M1.67M1.03M0.03M0.00M
Shares Outstanding 8.77M10.74M15.48M18.90M18.92M29.74M0.43M0.73M3.83M8.59M36.78M41.96M44.68M44.68M66.52M